Showing 281 - 300 results of 28,646 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 12 nm decrease ))', query time: 0.93s Refine Results
  1. 281
  2. 282

    Zinc exposure decreases NR1 clusters and NMDA currents. by Jia Zhu (135506)

    Published 2012
    “…Scale bar, 50 µm. (B) and (C) show the quantification of (A). …”
  3. 283
  4. 284
  5. 285
  6. 286
  7. 287
  8. 288
  9. 289
  10. 290
  11. 291

    Decreased oxidative phosphorylation in SDH and VHL-related PH/PGL. by Judith Favier (78711)

    Published 2013
    “…(D–F) Mean values for mitochondrial complexes II+III, III and IV reveal a generalized decrease in respiration in SDH and VHL PH/PGL. …”
  12. 292
  13. 293

    ROCK inhibition decreases the motility of MHCC97H cells. by Ji-Gang Zhang (278184)

    Published 2014
    “…(<b>B</b>) and (<b>D</b>) Data were normalized to untreated cells and the relative migration or invasion is expressed as mean ± S.E. of triplicate experiments. Fewer cells migrated or invaded 48 h after incubation with Y27632 (50 µM), compared with the control cells, *<i>P</i><0.05, **<i>P</i><0.01 and ***<i>P</i><0.001.…”
  14. 294

    ATRA decreased α-SMA expression in LT and HT cultures. by Carmen Retana (479628)

    Published 2013
    “…<p>(<b>A</b>) Immunofluorescence of omentum-derived mesothelial cells (control) and effluent-derived mesothelial cells from LT and HT grown until confluence in the presence of ATRA (0, 50 and 100 nM). …”
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    “…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”